Randomized Trialhigh evidence
Dual Stellate Ganglion Blocks for Managing Treatment-Resistant Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Pain physician·July 1, 2026·PMID 42550523
Why it mattersTreatment-resistant anxiety disorder poses a significant clinical challenge with limited therapeutic options. This trial provides rigorous evidence that a minimally invasive, ultrasound-guided procedure can produce clinically meaningful and sustained reductions in anxiety symptoms, offering a potential new avenue for patients who have not responded to conventional pharmacotherapy or psychotherapy.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled